REPORT ID 4190

EMEA (Europe, Middle East and Africa) Alpha Synuclein Market Report 2017

Publish Date
15-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the EMEA Alpha Synuclein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Alpha Synuclein for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Alpha Synuclein market competition by top manufacturers/players, with Alpha Synuclein sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AC Immune SA
    AFFiRiS AG
    BioArctic AB
    Biogen Inc
    Evotec AG
    Genmab A/S
    H. Lundbeck A/S
    ICB International Inc
    MedImmune LLC
    Neuropore Therapies Inc
    nLife Therapeutics SL
    Prothena Corp Plc
    QR Pharma Inc
    reMYND NV

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    AV-1950R
    AV-1947D
    BAN-0805
    BIIB-054
    DPC-003
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Multiple System Atrophy
    Neurodegenerateive Disease
    Lewy Body Dementia
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Alpha Synuclein Market Report 2017
1 Alpha Synuclein Overview
    1.1 Product Overview and Scope of Alpha Synuclein
    1.2 Classification of Alpha Synuclein
        1.2.1 EMEA Alpha Synuclein Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Alpha Synuclein Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 AV-1950R
        1.2.4 AV-1947D
        1.2.5 BAN-0805
        1.2.6 BIIB-054
        1.2.7 DPC-003
        1.2.8 Others
    1.3 EMEA Alpha Synuclein Market by Application/End Users
        1.3.1 EMEA Alpha Synuclein Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Multiple System Atrophy
        1.3.3 Neurodegenerateive Disease
        1.3.4 Lewy Body Dementia
        1.3.5 Others
    1.4 EMEA Alpha Synuclein Market by Region
        1.4.1 EMEA Alpha Synuclein Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Alpha Synuclein (2012-2022)
        1.5.1 EMEA Alpha Synuclein Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Alpha Synuclein Revenue and Growth Rate (2012-2022)

2 EMEA Alpha Synuclein Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Alpha Synuclein Market Competition by Players/Manufacturers
        2.1.1 EMEA Alpha Synuclein Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Alpha Synuclein Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Alpha Synuclein Sale Price by Players (2012-2017)
    2.2 EMEA Alpha Synuclein (Volume and Value) by Type/Product Category
        2.2.1 EMEA Alpha Synuclein Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Alpha Synuclein Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Alpha Synuclein Sale Price by Type (2012-2017)
    2.3 EMEA Alpha Synuclein (Volume) by Application
    2.4 EMEA Alpha Synuclein (Volume and Value) by Region
        2.4.1 EMEA Alpha Synuclein Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Alpha Synuclein Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Alpha Synuclein Sales Price by Region (2012-2017)

3 Europe Alpha Synuclein (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Alpha Synuclein Sales and Value (2012-2017)
        3.1.1 Europe Alpha Synuclein Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Alpha Synuclein Revenue and Growth Rate (2012-2017)
    3.2 Europe Alpha Synuclein Sales and Market Share by Type
    3.3 Europe Alpha Synuclein Sales and Market Share by Application
    3.4 Europe Alpha Synuclein Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Alpha Synuclein Sales Volume by Countries (2012-2017)
        3.4.2 Europe Alpha Synuclein Revenue by Countries (2012-2017)
        3.4.3 Germany Alpha Synuclein Sales and Growth Rate (2012-2017)
        3.4.4 France Alpha Synuclein Sales and Growth Rate (2012-2017)
        3.4.5 UK Alpha Synuclein Sales and Growth Rate (2012-2017)
        3.4.6 Russia Alpha Synuclein Sales and Growth Rate (2012-2017)
        3.4.7 Italy Alpha Synuclein Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Alpha Synuclein Sales and Growth Rate (2012-2017)

4 Middle East Alpha Synuclein (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Alpha Synuclein Sales and Value (2012-2017)
        4.1.1 Middle East Alpha Synuclein Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Alpha Synuclein Revenue and Growth Rate (2012-2017)
    4.2 Middle East Alpha Synuclein Sales and Market Share by Type
    4.3 Middle East Alpha Synuclein Sales and Market Share by Application
    4.4 Middle East Alpha Synuclein Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Alpha Synuclein Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Alpha Synuclein Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Alpha Synuclein Sales and Growth Rate (2012-2017)
        4.4.4 Israel Alpha Synuclein Sales and Growth Rate (2012-2017)
        4.4.5 UAE Alpha Synuclein Sales and Growth Rate (2012-2017)
        4.4.6 Iran Alpha Synuclein Sales and Growth Rate (2012-2017)

5 Africa Alpha Synuclein (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Alpha Synuclein Sales and Value (2012-2017)
        5.1.1 Africa Alpha Synuclein Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Alpha Synuclein Revenue and Growth Rate (2012-2017)
    5.2 Africa Alpha Synuclein Sales and Market Share by Type
    5.3 Africa Alpha Synuclein Sales and Market Share by Application
    5.4 Africa Alpha Synuclein Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Alpha Synuclein Sales Volume by Countries (2012-2017)
        5.4.2 Africa Alpha Synuclein Revenue by Countries (2012-2017)
        5.4.3 South Africa Alpha Synuclein Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Alpha Synuclein Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Alpha Synuclein Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Alpha Synuclein Sales and Growth Rate (2012-2017)

6 EMEA Alpha Synuclein Manufacturers/Players Profiles and Sales Data
    6.1 AC Immune SA
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Alpha Synuclein Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AC Immune SA Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AFFiRiS AG
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Alpha Synuclein Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 BioArctic AB
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Alpha Synuclein Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BioArctic AB Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Biogen Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Alpha Synuclein Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Biogen Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Evotec AG
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Alpha Synuclein Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Evotec AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Genmab A/S
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Alpha Synuclein Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Genmab A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 H. Lundbeck A/S
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Alpha Synuclein Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 ICB International Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Alpha Synuclein Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 ICB International Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 MedImmune LLC
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Alpha Synuclein Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Neuropore Therapies Inc
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Alpha Synuclein Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 nLife Therapeutics SL
    6.12 Prothena Corp Plc
    6.13 QR Pharma Inc
    6.14 reMYND NV

7 Alpha Synuclein Manufacturing Cost Analysis
    7.1 Alpha Synuclein Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Alpha Synuclein

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Alpha Synuclein Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Alpha Synuclein Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Alpha Synuclein Market Forecast (2017-2022)
    11.1 EMEA Alpha Synuclein Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Alpha Synuclein Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Alpha Synuclein Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Alpha Synuclein Price and Trend Forecast (2017-2022)
    11.2 EMEA Alpha Synuclein Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Alpha Synuclein Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Alpha Synuclein Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Alpha Synuclein Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Alpha Synuclein Sales Forecast by Type (2017-2022)
    11.7 EMEA Alpha Synuclein Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer